Caspases inhibition decreases neurological sequelae in meningitis

Jose Irazuzta, Robert K. Pretzlaff, Basilia Zingarelli

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

OBJECTIVE: To evaluate the effects of sustained caspase inhibition during the acute phase of meningitis-induced brain injury. Changes in neurobehavioral performance were the primary outcome variables. DESIGN: Randomized prospective animal study. SETTING: University research laboratory. SUBJECTS: Male Wistar rats. INTERVENTIONS: Animals underwent a basilar cistern inoculation of group B Streptococci to induce meningitis. Sixteen hours later animals were randomized to receive Bocaspartyl (OMe)-fluoromethyketone (BAF) for 4 days or placebo in addition to antibiotic therapy. The assessment of neurobehavioral performance was started 7 days after initiation of treatment and continued for the following 3 wks. A subgroup underwent early kill, at 5 days, to evaluate caspase 3 activity in brain tissue. There was a group of Sham instrumented animals. MEASUREMENTS AND MAIN RESULTS: BAF decreased caspase 3 activation in meningitic animals. There were no significant motor deficit differences between the infected groups. Cognitive performance was significantly improved in the BAF group. CONCLUSION: These findings demonstrate that sustained systemic administration of BAF inhibits caspase 3 activation and decreases neurologic sequelae in a rat model of bacterial meningitis.

Original languageEnglish (US)
Pages (from-to)1603-1606
Number of pages4
JournalCritical Care Medicine
Volume36
Issue number5
DOIs
StatePublished - May 2008

Fingerprint

Caspases
Meningitis
Caspase 3
Bacterial Meningitides
Streptococcus agalactiae
Brain Injuries
Nervous System
Wistar Rats
Placebos
Prospective Studies
Anti-Bacterial Agents
Brain
Therapeutics
Research

Keywords

  • Brain injury
  • Caspase 3
  • Meningitis
  • Neurobehavioral performance

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Caspases inhibition decreases neurological sequelae in meningitis. / Irazuzta, Jose; Pretzlaff, Robert K.; Zingarelli, Basilia.

In: Critical Care Medicine, Vol. 36, No. 5, 05.2008, p. 1603-1606.

Research output: Contribution to journalArticle

Irazuzta, Jose ; Pretzlaff, Robert K. ; Zingarelli, Basilia. / Caspases inhibition decreases neurological sequelae in meningitis. In: Critical Care Medicine. 2008 ; Vol. 36, No. 5. pp. 1603-1606.
@article{9ee6c4779d31456f976b5d8962759dc5,
title = "Caspases inhibition decreases neurological sequelae in meningitis",
abstract = "OBJECTIVE: To evaluate the effects of sustained caspase inhibition during the acute phase of meningitis-induced brain injury. Changes in neurobehavioral performance were the primary outcome variables. DESIGN: Randomized prospective animal study. SETTING: University research laboratory. SUBJECTS: Male Wistar rats. INTERVENTIONS: Animals underwent a basilar cistern inoculation of group B Streptococci to induce meningitis. Sixteen hours later animals were randomized to receive Bocaspartyl (OMe)-fluoromethyketone (BAF) for 4 days or placebo in addition to antibiotic therapy. The assessment of neurobehavioral performance was started 7 days after initiation of treatment and continued for the following 3 wks. A subgroup underwent early kill, at 5 days, to evaluate caspase 3 activity in brain tissue. There was a group of Sham instrumented animals. MEASUREMENTS AND MAIN RESULTS: BAF decreased caspase 3 activation in meningitic animals. There were no significant motor deficit differences between the infected groups. Cognitive performance was significantly improved in the BAF group. CONCLUSION: These findings demonstrate that sustained systemic administration of BAF inhibits caspase 3 activation and decreases neurologic sequelae in a rat model of bacterial meningitis.",
keywords = "Brain injury, Caspase 3, Meningitis, Neurobehavioral performance",
author = "Jose Irazuzta and Pretzlaff, {Robert K.} and Basilia Zingarelli",
year = "2008",
month = "5",
doi = "10.1097/CCM.0b013e318170ab08",
language = "English (US)",
volume = "36",
pages = "1603--1606",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Caspases inhibition decreases neurological sequelae in meningitis

AU - Irazuzta, Jose

AU - Pretzlaff, Robert K.

AU - Zingarelli, Basilia

PY - 2008/5

Y1 - 2008/5

N2 - OBJECTIVE: To evaluate the effects of sustained caspase inhibition during the acute phase of meningitis-induced brain injury. Changes in neurobehavioral performance were the primary outcome variables. DESIGN: Randomized prospective animal study. SETTING: University research laboratory. SUBJECTS: Male Wistar rats. INTERVENTIONS: Animals underwent a basilar cistern inoculation of group B Streptococci to induce meningitis. Sixteen hours later animals were randomized to receive Bocaspartyl (OMe)-fluoromethyketone (BAF) for 4 days or placebo in addition to antibiotic therapy. The assessment of neurobehavioral performance was started 7 days after initiation of treatment and continued for the following 3 wks. A subgroup underwent early kill, at 5 days, to evaluate caspase 3 activity in brain tissue. There was a group of Sham instrumented animals. MEASUREMENTS AND MAIN RESULTS: BAF decreased caspase 3 activation in meningitic animals. There were no significant motor deficit differences between the infected groups. Cognitive performance was significantly improved in the BAF group. CONCLUSION: These findings demonstrate that sustained systemic administration of BAF inhibits caspase 3 activation and decreases neurologic sequelae in a rat model of bacterial meningitis.

AB - OBJECTIVE: To evaluate the effects of sustained caspase inhibition during the acute phase of meningitis-induced brain injury. Changes in neurobehavioral performance were the primary outcome variables. DESIGN: Randomized prospective animal study. SETTING: University research laboratory. SUBJECTS: Male Wistar rats. INTERVENTIONS: Animals underwent a basilar cistern inoculation of group B Streptococci to induce meningitis. Sixteen hours later animals were randomized to receive Bocaspartyl (OMe)-fluoromethyketone (BAF) for 4 days or placebo in addition to antibiotic therapy. The assessment of neurobehavioral performance was started 7 days after initiation of treatment and continued for the following 3 wks. A subgroup underwent early kill, at 5 days, to evaluate caspase 3 activity in brain tissue. There was a group of Sham instrumented animals. MEASUREMENTS AND MAIN RESULTS: BAF decreased caspase 3 activation in meningitic animals. There were no significant motor deficit differences between the infected groups. Cognitive performance was significantly improved in the BAF group. CONCLUSION: These findings demonstrate that sustained systemic administration of BAF inhibits caspase 3 activation and decreases neurologic sequelae in a rat model of bacterial meningitis.

KW - Brain injury

KW - Caspase 3

KW - Meningitis

KW - Neurobehavioral performance

UR - http://www.scopus.com/inward/record.url?scp=42949129601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42949129601&partnerID=8YFLogxK

U2 - 10.1097/CCM.0b013e318170ab08

DO - 10.1097/CCM.0b013e318170ab08

M3 - Article

VL - 36

SP - 1603

EP - 1606

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 5

ER -